• Like
  • Comment
  • Favorite

West Pharmaceutical Services Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones03-21 05:10

DJ West Pharmaceutical Services Inc. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of West Pharmaceutical Services Inc. (WST) shed 1.37% to $237.03 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 1.51% to 6,506.48 and Dow Jones Industrial Average falling 0.96% to 45,577.47.

West Pharmaceutical Services Inc. closed 26.47% short of its 52-week high of $322.34, which the company achieved on October 23rd.

Despite its losses, the stock outperformed some of its competitors Friday, as Abbott Laboratories $(ABT)$ fell 1.61% to $105.46, Becton Dickinson & Co. $(BDX)$ fell 1.53% to $154.13, and Baxter International Inc. $(BAX)$ fell 3.06% to $16.15.

Trading volume (1.2 M) eclipsed its 50-day average volume of 1.0 M.

Data source: Dow Jones Market Data, FactSet. Data compiled March 20, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

March 20, 2026 17:10 ET (21:10 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

empty
No comments yet
 
 
 
 

Most Discussed

 
 
 
 
 

7x24